Siemens AG — Earnings Release 2010

Sep 21, 2010

News Details

Ad-hoc | 21 September 2010 22:15

Siemens Aktiengesellschaft: Siemens Healthcare adjusts goodwill in the Diagnostics Division

Siemens Aktiengesellschaft / Key word(s): Miscellaneous

21.09.2010 22:15

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

The Siemens Healthcare Sector will adjust goodwill of presumably up to
EUR1.4 billion in the fourth quarter of fiscal 2010. This impairment is
being made in connection with a reevaluation of medium-term growth
prospects and long-term market developments of the laboratory diagnostics
business. Siemens acquired DPC, Bayer Diagnostics and Dade Behring in 2006
and 2007, merging them to create one of the world's leading provider of
laboratory diagnostics. The impairment has no cash impact and leaves the
company's outlook for fiscal 2010 unaffected.

---

Information and Explaination of the Issuer to this News:

This document contains forward-looking statements and information - that
is, statements related to future, not past, events. These statements may be
identified by words such as 'expects,' 'looks forward to', 'anticipates',
'intends', 'plans', 'believes', 'seeks', 'estimates', 'will', 'project' or
words of similar meaning. Such statements are based on the current
expectations and certain assumptions of Siemens' management, and are,
therefore, subject to certain risks and uncertainties. A variety of
factors, many of which are beyond Siemens' control, affect Siemens'
operations, performance, business strategy and results and could cause the
actual results, performance or achievements of Siemens to be materially
different from any future results, performance or achievements that may be
expressed or implied by such forward-looking statements. For Siemens,
particular uncertainties arise, among others, from changes in general
economic and business conditions (including margin developments in major
business areas and recessionary trends); the possibility that customers may
delay the conversion of booked orders into revenue or that prices will
decline as a result of continued adverse market conditions to a greater
extent than currently anticipated by Siemens' management; developments in
the financial markets, including fluctuations in interest and exchange
rates, commodity and equity prices, debt prices (credit spreads) and
financial assets generally; continued volatility and a further
deterioration of the capital markets; a worsening in the conditions of the
credit business and, in particular, additional uncertainties arising out of
the subprime, financial market and liquidity crises; future financial
performance of major industries that Siemens serves, including, without
limitation, the Sectors Industry, Energy and Healthcare; the challenges of
integrating major acquisitions and implementing joint ventures and other
significant portfolio measures; the introduction of competing products or
technologies by other companies; a lack of acceptance of new products or
services by customers targeted by Siemens; changes in business strategy;
the outcome of pending investigations and legal proceedings and actions
resulting from the findings of these investigations; the potential impact
of such investigations and proceedings on Siemens' ongoing business
including its relationships with governments and other customers; the
potential impact of such matters on Siemens' financial statements; as well
as various other factors. More detailed information about certain of the
risk factors affecting Siemens is contained throughout this report and in
Siemens' other filings with the SEC, which are available on the Siemens
website, www.siemens.com, and on the SEC's website, www.sec.gov. Should one
or more of these risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially from those
described in the relevant forward-looking statement as expected,
anticipated, intended, planned, believed, sought, estimated or projected.
Siemens does not intend or assume any obligation to update or revise these
forward-looking statements in light of developments which differ from those
anticipated.

Siemens Investor Relations
Tel.: +49 89 636 32474
Fax: +49 89 636 32830
Mail: investorrelations@siemens.com

21.09.2010 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: Siemens Aktiengesellschaft
Wittelsbacherplatz 2
80333 München
Deutschland
Phone: +49 (0)89 636-00
Fax: +49 (0)89 636-52000
E-mail: investorrelations@siemens.com
Internet: www.siemens.com
ISIN: DE0007236101
WKN: 723610
Indices: DAX, EURO STOXX 50
Listed: Regulierter Markt in Frankfurt (Prime Standard), Berlin,
Hannover, Stuttgart, Hamburg, München, Düsseldorf;
Terminbörse EUREX; Foreign Exchange(s) London, NYSE, SIX

End of Announcement DGAP News-Service

---